# Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer

> **NCT00027664** · PHASE2 · UNKNOWN · sponsor: **Cancer Research UK** · enrollment: 90 (estimated)

## Conditions studied

- Kidney Cancer

## Interventions

- **BIOLOGICAL:** recombinant interferon alfa
- **DRUG:** thalidomide

## Key facts

- **NCT ID:** NCT00027664
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2013-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00027664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00027664, "Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00027664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*